Document is current
Any future updates will be listed below
-
Authors
Querques, Irma http://orcid.org/0000-0003-1113-2773
Mades, Andreas
Zuliani, Cecilia http://orcid.org/0000-0001-6026-7207
Miskey, Csaba http://orcid.org/0000-0002-7566-9556
Alb, Miriam http://orcid.org/0000-0001-6454-9906
Grueso, Esther
Machwirth, Markus
Rausch, Tobias http://orcid.org/0000-0001-5773-5620
Einsele, Hermann
Ivics, Zoltán http://orcid.org/0000-0002-7803-6658
Hudecek, Michael http://orcid.org/0000-0002-2280-2202
Barabas, Orsolya http://orcid.org/0000-0002-2873-5872
-
Funding
Funding for this research was provided by:
European Molecular Biology Laboratory
Hessisches Ministerium für Wissenschaft und Kunst (LOEWE)
Deutsche Krebshilfe (Max Eder Program Award 110313)
Bayerische Akademie der Wissenschaften (m4 Award in Personalized Medicine, Junger Kolleg)
EMBL International PhD Programme
Paul Ehrlich Institute
Paul Ehrlich Institute
Paul Ehrlich Institute
-
License Information
Text and Data Mining valid from 2019-11-04
Version of Record valid from 2019-11-04
-
More Information
Article History
Received: 25 June 2019
Accepted: 13 September 2019
First Online: 4 November 2019
Competing interests
: Z.I. is an inventor on patents concerning the development and use of the <i>Sleeping Beauty</i> technology (proprietor Max-Delbrück-Centrum für Molekulare Medizin; patents US9228180B2 and EP2160461B1), and two patent applications have been filed with the European Patent Office concerning the hsSB transposase (EP17187128 and EP19158066.1).
